- The Beauty Health press release (NASDAQ:SKIN): Q4 GAAP EPS of -$0.07 beats by $0.03.
- Revenue of $96.8M (-1.4% Y/Y) beats by $9.19M.
- Adjusted gross margin was 54.6% in Q4 2023 compared to 73.6% in Q4 2022. Gross margin and adjusted gross margin were adversely impacted by higher inventory related charges and higher product and warranty costs.
- Adjusted EBITDA was $3.4 million in Q4 2023 compared to adjusted EBITDA of $17.6 million in Q4 2022, primarily due to gross margin pressures.
- The Company placed 1,551 delivery systems during the quarter compared to 2,067 in the prior year period; challenges in the Americas and EMEA were partially offset by growth in APAC.
- Shares +24.23%.
The Beauty Health GAAP EPS of -$0.07 beats by $0.03, revenue of $96.8M beats by $9.19M
Recommended For You
More Trending News
About SKIN Stock
Related Stocks
| Symbol | Last Price | % Chg |
|---|---|---|
| SKIN | - | - |
| The Beauty Health Company | ||